Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer

被引:0
|
作者
Kawabe, Nozomi [1 ]
Muraki, Nao [1 ]
Tanaka, Ichidai [2 ]
Sunaga, Noriaki [3 ]
Sato, Mitsuo [1 ]
机构
[1] Nagoya Univ, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[3] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-3031
引用
收藏
页码:1547 / 1547
页数:1
相关论文
共 50 条
  • [41] KRAS as a Therapeutic Target
    McCormick, Frank
    CLINICAL CANCER RESEARCH, 2015, 21 (08) : 1797 - 1801
  • [42] Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
    Dong, Tianyu
    Zhang, Bo
    Zhang, Runjiao
    Wang, Chang
    Liu, Xiaopeng
    Wang, Fei
    Hao, Nana
    Tan, Ke
    Chang, Yan-Zhong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang
    Mingyao Liu
    Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
  • [44] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    CHINESE JOURNAL OF CANCER, 2016, 35 : 92
  • [45] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Michael J. Duffy
    Naoise C. Synnott
    John Crown
    Breast Cancer Research and Treatment, 2018, 170 : 213 - 219
  • [46] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Duffy, Michael J.
    Synnott, Naoise C.
    Crown, John
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 213 - 219
  • [47] KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
    Waters, Andrew M.
    Der, Channing J.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (09):
  • [48] Kras as a key oncogene and therapeutic target in pancreatic cancer
    Collins, Meredith A.
    di Magliano, Marina Pasca
    FRONTIERS IN PHYSIOLOGY, 2014, 4
  • [49] Development of siRNA Payloads to Target KRAS-Mutant Cancer
    Yuan, Tina L.
    Fellmann, Christof
    Lee, Chih-Shia
    Ritchie, Cayde D.
    Thapar, Vishal
    Lee, Liam G.
    Hsu, Dennis J.
    Grace, Danielle
    Carver, Joseph O.
    Zuber, Johannes
    Luo, Ji
    McCormick, Frank
    Lowe, Scott W.
    CANCER DISCOVERY, 2014, 4 (10) : 1182 - 1197
  • [50] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
    Knickelbein, Kyle
    Zhang, Lin
    GENES & DISEASES, 2015, 2 (01) : 4 - 12